Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by adamchesson Mar 17, 2016 6:33pm
137 Views
Post# 24672623

RE:RE:RE:RE:RE:RE:IBB almost FLAT

RE:RE:RE:RE:RE:RE:IBB almost FLATNot saying your alias is notwrong at all. Since you brought it up my guess is ChartSchool. Not sure why you take on such strong names on SH?

Without knowing all the intricacies of AMCo or Concordia pre-AMCo, I don't really see the issues you state as being over-whelming. I don"t see AMCo and Concordia being integrated, which I believe MT had also expressed. From all indications, AMCo is a first class corporate citizen and I guess they may benefit from Concordia's tax structure if there is an amalgamation of the two companies. I believe AMCo's financing was even more stretched prior to the acquisition and it is now in a better place in that respect. I don't see any significant debt reductions by Concordia during 2016 unless there is a huge cash surplus from revenue increases or selling off assets, after the performanc bonus payment to Cinven. Regards, Adamchess


DeathPool wrote: Hi Adam, You are correct in your observation that many of the Fortune 500 achieved their membership in that exclusive club by such strategies.  But there are other issues involved in M&A:  targeting the right acquisition, valuation, tax structure, financing structure, due diligence, corporate integration....   to name a few.   I am sure that you will agree that assessing the market value of AMCo is a complex undertaking and that is why much of the investment houses are on the sidelines. There is no such thing as "easy money" as you have said in an earlier post of yours when you declared that you had purchased more shares today.  

Currently, the sentiment in the investment community is that pharma companies must solve problems and not just be cash generating machines but they must be innovation engines and must position themselves differently with patients, physicians and scientists than they have done in the past.  Posters on this board are so emphatic that we are so different from Valeant, but yet the share price doesn't seem to be agreeing.  And isn't price the final arbiter?  

I am not asking that you share my opinion.  All I ask is that you have a minuscule amount of respect and not proceed to accuse me of being an alias of notwrong here.  


adamchess wrote: I am pretty sure that is how most large multi-national companies have grown to top 100 companies. As an accountant these companies make your head hurt how many subsidiaries they have. You guys are a one trick pony excuse for investors. Tomorrow you say leverage at low interest rates is great.

DeathPool wrote: debt....  growth by acquistion strategy .....  Are you just grasping this now, Adamchess?

We most swim do swim in the same ocean.  And said someone once, you don't know who is swimming naked until the tide goes out. 

 




<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse